Corentin Orvain
32PUBLICATIONS
115CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (32)
Sort by Publication Date:
|Mar 19, 2026
Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial.Mathilde Taillantou-Candau, Achille Kouatchet, Astrid Darsonval
|Nov 14, 2025
Pleural Infiltration Revealing Post-Essential Thrombocythemia Acute Myeloid Leukaemia.Clémentine Muron, Damien Luque Paz, Marie-Christine Copin
|Oct 08, 2025
Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability.Marie Sébert, Sylvain Thepot, Thomas Cluzeau
|Sep 12, 2025
Association Between Molecular Profile and Outcome After Intensive Chemotherapy in Patients > 60 Years With Secondary and/or Adverse Cytogenetics Acute Myeloid Leukemia-A FILO Study.Corentin Orvain, Anne Bouvier, Audrey Bidet
|Sep 08, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla
|Aug 21, 2025
Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study.Jules Higué, Corentin Orvain, Pierre-Yves Dumas
Pageof 6
Frequent Collaborators
7 joint publications
Damien Luque Paz
6 joint publications
Sarah Bertoli
6 joint publications
Roland Walter
4 joint publications
Brenda Sandmaier
4 joint publications
Christian Récher
4 joint publications
Jérémie Riou
4 joint publications
Mathilde Hunault-Berger
4 joint publications
Megan Othus
3 joint publications
Ambroise Marcais
3 joint publications
Edouard Forcade
